AliveLongevity
ProtocolStart HereBlogResourcesPricingAbout

Article library · Science

Science

10 evidence reviews in this category. Every piece states what the human data shows, how large the effect is, and when to talk to a clinician instead.

  • March 28, 2026 · 16 min read

    Rapamycin for Longevity: What the 2026 Evidence Actually Shows

    Rapamycin is the most discussed prescription longevity drug — and also the most misunderstood. A deep-dive into mTOR biology, the PEARL trial, real-world off-label use, and the honest risk framework for longevity readers.

  • March 20, 2026 · 14 min read

    GLP-1 Agonists Beyond Weight Loss: What the 2026 Evidence Shows for Heart, Brain, and Longevity

    Oral semaglutide just received FDA approval. SELECT showed 20% MACE reduction independent of weight. FLOW showed kidney protection. And signals are emerging for neuroprotection. Here is the complete evidence update on what GLP-1 drugs are proving to do beyond weight loss — and what it means for longevity.

  • March 6, 2026 · 20 min read

    Rapamycin Anti-Aging Guide: What Longevity Readers Should Understand

    A measured rapamycin guide covering why it attracts anti-aging interest, what remains uncertain, and how to think about risk, monitoring, and expectations.

  • March 1, 2026 · 17 min read

    Senolytics Guide for Longevity: Dasatinib Plus Quercetin, Fisetin, and Practical Risk Management

    A detailed senolytics primer for longevity readers covering mechanism hypotheses, protocol uncertainty, safety constraints, and decision criteria before experimentation.

  • February 25, 2026 · 11 min read

    Rapamycin for Longevity: What We Know So Far

    A balanced review of rapamycin for longevity, covering mechanism, current evidence, uncertainty, and clinician-supervised risk management.

  • February 23, 2026 · 17 min read

    Stem Cell Therapy for Longevity in 2026: Overview, Claims, and Decision Guardrails

    A balanced stem cell therapy overview for longevity readers, covering realistic indications, evidence gaps, clinic due diligence, and risk-aware decision-making.

  • January 21, 2026 · 9 min read

    Peter Attia's Longevity Framework Explained

    A practical breakdown of Peter Attia's core longevity pillars and how to apply the framework without overcomplicating execution.

  • December 22, 2025 · 11 min read

    GLP-1 Agonists and Longevity: Beyond Weight Loss

    A practical review of GLP-1 agonists through a longevity lens, including metabolic benefits, body composition concerns, and long-term strategy.

  • November 12, 2025 · 12 min read

    Stem Cell Therapy for Anti-Aging: State of the Art

    A state-of-the-art overview of stem cell therapy for anti-aging, including current evidence, real constraints, and safety concerns.

  • November 6, 2025 · 10 min read

    Telomere Length: Can You Actually Reverse Aging?

    A science-focused review of telomere length claims, testing limitations, and what telomere data can realistically tell you.

Disclosure: Educational content only. This site does not provide medical diagnosis or treatment. Always discuss supplements, labs, and medication changes with a licensed clinician.

Get the weekly research brief

One evidence review, one protocol, one metric to track. Every Friday, no filler.

No spam, unsubscribe anytime. See our privacy policy.

AliveLongevity

Practical, evidence-first guidance for a longer healthspan. Human outcomes over hype.

Explore

  • Longevity Protocol
  • Start Here
  • Blog
  • Resources
  • Healthspan Quiz
  • Longevity Blueprint

Site

  • About
  • Pricing
  • Privacy
  • Terms
© 2026 AliveLongevity. Educational content, not medical advice.Sister sites: protocolrank.com and peakedlabs.com